| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/10/2008 | CN101259142A Bone peptide injection preparation |
| 09/10/2008 | CN100417727C Medical preparations for treatment of alpha-galactosidase A deficiency |
| 09/09/2008 | US7423137 Nucleic acids encoding recombinant 56 and 82 kDa antigens from gametocytes of Eimeria maxima and their uses |
| 09/09/2008 | US7423135 Expression vector comprising rodent regulatory sequences for use as gene expression control tools in genetic engineering |
| 09/09/2008 | US7423134 Protein AMSH and cDNA thereof |
| 09/09/2008 | US7423130 A nucleic acid sequence encoding the polypeptide, lacking its associated signal peptide |
| 09/09/2008 | US7423127 For diagnosis and therapy |
| 09/09/2008 | US7423123 Interleukin-9 antagonist muteins and their pharmacological methods of use |
| 09/09/2008 | US7423122 N-terminal and C-terminal markers in nascent proteins |
| 09/09/2008 | US7423120 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders |
| 09/09/2008 | US7423118 IAPS associated cell cycle proteins, compositions and methods of use |
| 09/09/2008 | US7423018 Using motor proteins to identify agents for prevention and treatment of cell proliferative and autoimmune disorders; RNA interference and gene expression inhibition; ribozymes |
| 09/09/2008 | US7422906 Apoptosis-inducing gene and utilization of the same |
| 09/09/2008 | US7422886 Human Phosphoinositide I3 Kinase p110 Delta which interacts with p85, has a broad phosphinositide specificity and is sensitive to the same kinase inhibitors as PI3 Kinase p110A; selectively expressed in leucocytes; enhanced expression in most melanomas |
| 09/09/2008 | US7422884 Especially feedback inhibition by farnesyl diphosphate or geranylgeranyl diphosphate; producing isoprenoid compounds, particularly coenzyme Q10 |
| 09/09/2008 | US7422877 Activatable recombinant neurotoxins |
| 09/09/2008 | US7422876 Methods for generating cellulases |
| 09/09/2008 | US7422875 Incubating cells with a heterologous nucleic acid encoding a recombinant protein in a media containing amphiphilic copolymer having at least one block of poly(oxyethylene) and at least one block of poly(oxypropylene) optionally initiated by ethylenediamine or polyethylenimine; enhanced gene expression |
| 09/09/2008 | US7422874 Expression vector for animal cell |
| 09/09/2008 | US7422863 Molting hormone receptor and method for screening ligand to the receptor |
| 09/09/2008 | US7422861 Oligonucleotide transfection screening method |
| 09/09/2008 | US7422849 Hybridizing sample with a nucleic acid molecule to a transcript of gene wherein said transcript is RNA or cDNA; determining hybridization as a determination of expression of gene |
| 09/09/2008 | US7422754 Neisseria meningitidis (Nm) polynucleotides and polypeptides; diagnostic. prophylactic and therapeutic uses |
| 09/09/2008 | US7422744 Integrin mediated diseases like angiogenesis or restenosis; Vitaxin (a humanized monoclonal) antibody and a LM609 grafted antibody exhibiting selective binding affinity to alpha v beta 3 |
| 09/09/2008 | US7422742 Gene therapy using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders, administering antibody or antigen-binding fragment thereof that specifically binds IL-5 |
| 09/09/2008 | US7422741 VEGFR-3 fusion proteins |
| 09/09/2008 | US7422739 Anti-CD20 antibodies |
| 09/09/2008 | US7422734 Methods of producing lignin peroxidase and its use in skin and hair lightening |
| 09/09/2008 | CA2419696C Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes |
| 09/09/2008 | CA2323086C Regulation of endogenous gene expression in cells using zinc finger proteins |
| 09/09/2008 | CA2173999C An aglucone isoflavone enriched vegetable protein whey, whey protein, and process for producing |
| 09/09/2008 | CA2144855C Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 09/09/2008 | CA2133644C Process for making vancomycin |
| 09/08/2008 | CA2621608A1 Methods of optimizing the secretion of protein in prokaryotes |
| 09/04/2008 | WO2008106660A2 Isolated phospholipid-protein particles |
| 09/04/2008 | WO2008105886A2 HUMANIZED FCγRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF |
| 09/04/2008 | WO2008105560A1 Pharmaceutical composition comprising anti-grp78 antibody as active ingredient |
| 09/04/2008 | WO2008105454A1 Cell capable of expressing lacritin at high level |
| 09/04/2008 | WO2008088757A3 Apparatus and methods for osmotically shocking cells |
| 09/04/2008 | WO2007130060A3 Isolation and therapeutic application of adult retinal stem cells collected from extra-retinal tissues |
| 09/04/2008 | US20080216184 Modulating the expression of a gene in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms |
| 09/04/2008 | US20080214790 Leafthopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 09/04/2008 | US20080214788 Interferon-like protein zcyto21 |
| 09/04/2008 | US20080214785 Heterodimeric receptor complex which antagonizes IL-10-related T cell-derived inducible factor for use in diagnosis, treatment and prevention of spleen associated cell proliferative disorders |
| 09/04/2008 | US20080214464 Method for the Production of Biologically Active Rhngf |
| 09/04/2008 | US20080214462 FIX-Mutant Proteins for Hemophilia B Treatment |
| 09/04/2008 | US20080214461 FVIII-Independent FIX-Mutant Proteins for Hemophilia A Treatment |
| 09/04/2008 | US20080214450 Nucleic acid constructs, recombinant expression vectors, and recombinant host cells comprising the polynucleotides |
| 09/04/2008 | US20080214447 For treatment of hepatitis C |
| 09/04/2008 | US20080214439 Amino acid substituted molecules |
| 09/04/2008 | US20080214411 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 09/04/2008 | US20080214403 Parallel Methods For Insertional Mutagenesis |
| 09/04/2008 | US20080213901 Methods for producing heterologous polypeptides in trichothecene-deficient filamentous fungal mutant cells |
| 09/04/2008 | US20080213886 Albumin fusion proteins |
| 09/04/2008 | US20080213881 Expression vector coding nucleotide sequences comprising novel cytokine upregulated by interleukin-9 for use in treatment and prevention of cell hodgkin's disease |
| 09/04/2008 | US20080213840 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides |
| 09/04/2008 | US20080213839 Nucleotide sequences coding stem cell factors for use as therapeutic tools in treating learning and memory disorders |
| 09/04/2008 | US20080213838 Expression vector comprising nucleotide sequences coding aminopeptidase A (APA) protein for use in prvention and treatment of preclampsia |
| 09/04/2008 | US20080213837 Apo-3 ligand polypeptide |
| 09/04/2008 | US20080213836 Modified enteropeptidase protein |
| 09/04/2008 | US20080213835 Polypeptides Having Cellobiohydrolase II Activity And Polynucleotides Encoding Same |
| 09/04/2008 | US20080213834 Gsk3 ligands and polynucleotides encoding gsk3 ligands |
| 09/04/2008 | US20080213833 Methods for Obtaining Optically Active Glycidyl Ethers and Optically Active Vicinal Diols from Racemic Substrates |
| 09/04/2008 | US20080213831 Human cytokine receptor |
| 09/04/2008 | US20080213830 Modified botulinum toxin comprising translocation, enzymatic and binding domains for use in cosmetics and treatment of pain disorders |
| 09/04/2008 | US20080213829 Expression vector comprising nucleotide sequences coding glutamine synthetases for enhancing biosynthesis of polypeptides |
| 09/04/2008 | US20080213828 Glycoprotein synthesis |
| 09/04/2008 | US20080213827 Process For Producing Dipeptides or Dipeptide Derivatives |
| 09/04/2008 | US20080213803 Using proopiomelanocortin neuronal regulatory sequences to identify agents that affects caloric intake, energy expenditure, appetite or food intake; treating eating disorders and/or cachexia |
| 09/04/2008 | US20080213795 Plasmodium epitope polypeptide for use in treatment and prevention malarial infection |
| 09/04/2008 | US20080213793 Antibodies that bind receptor protein designated 2f1 |
| 09/04/2008 | US20080213778 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 09/04/2008 | US20080213430 nucleic acid constructs, vectors, and host cells; detergents; transgenic plants; animal feeds |
| 09/04/2008 | US20080213318 Insect cell expression system provides high yields of recombinant subunit proteins with native-like conformation; secreted from transformed Drosophila melanogaster S2 cells; truncated malaria merozoite surface protein, MSP-1; inhibitory antibodies inhibiting parasite growth |
| 09/04/2008 | US20080213315 free of non-300 kD botulinum toxin type A complexes |
| 09/04/2008 | US20080213311 Neuropeptide Y, kyotorphin, calcitonin-gene related peptides bind receptors; Clostridial toxin HN domain translocates toxin light chain across endosome membrane;Clostridial toxin light chain cleaves a neurosecretory protein; HC domain modified to reduce binding to receptors at neuromuscular junction |
| 09/04/2008 | US20080213310 Use of lytic toxins and toxin conjugates |
| 09/04/2008 | US20080213303 Genetically modified cholera toxin (CT-CRM) comprising reduced toxicity and enhanced immunological response for use in preparation of vaccines against parasitic infection |
| 09/04/2008 | US20080213294 Immunization of dairy cattle with GapC protein against streptococcus infection |
| 09/04/2008 | US20080213289 Recombinant anti-cd30 antibodies and uses thereof |
| 09/04/2008 | US20080213277 Peptide hormone specific monoclonal antibody for use in diagnosis, prognosis, prevention and treatment of blood, cell proliferative, inflammatory, kidney and liver disorders |
| 09/04/2008 | US20080213272 Vegf-related protein |
| 09/04/2008 | US20080213256 Less Immunogenic Binding Molecules |
| 09/04/2008 | US20080213254 Immunoglobulin capable of linking immunoreceptor tyrosine-based activation motif (ITAM) with immunoreceptor tyrosine-based inhibition motif (ITIM) for use in treatment of allergic disorders; gene therapy |
| 09/04/2008 | US20080213216 Transgenic lymphocytes comprising expression vector coding Fc receptor for use in identifying modulators for prevention and treatment of ifection and immune system disorders |
| 09/04/2008 | CA2679266A1 Pharmaceutical composition comprising anti-grp78 antibody as active ingredient |
| 09/03/2008 | EP1964923A1 Multiplex fermentation process |
| 09/03/2008 | EP1964921A2 The high bone mass gene of 11q13.3 |
| 09/03/2008 | EP1964916A1 Multi-purpose acylation catalayst and use thereof |
| 09/03/2008 | EP1964852A1 Anti-ilt7 antibody |
| 09/03/2008 | EP1964850A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 09/03/2008 | EP1964572A2 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 09/03/2008 | EP1963518A1 Sophorolipids as protein inducers and inhibitors in fermentation medium |
| 09/03/2008 | EP1963494A1 Phage particle diagnostic reagents |
| 09/03/2008 | EP1963366A2 Methods for cyclic nucleotide determination |
| 09/03/2008 | EP1962961A1 Demibodies: dimerisation-activated therapeutic agents |
| 09/03/2008 | EP1907854A4 Monoclonal antibodies, hybridoma cell lines, methods and kits for detecting phytase |
| 09/03/2008 | EP1861499A4 Methods and compositions for producing active vitamin k-dependent proteins |
| 09/03/2008 | EP1476468B1 Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity |
| 09/03/2008 | EP1291429B1 Glutamine fructose-6-phosphate amidotransferase splice variant and its expression product |